English

Prostate cancer blood test 'helps target treatment'

BBC / Health 13 sources

By detecting cancer DNA in blood, the test can identify which men will benefit from precision drugs.

Prostate cancer blood test could transform treatment, say scientists

The Guardian / AU

Three-in-one test reveals which men with advanced cancer are suitable for treatment with ‘precision’ drug olaparib

New blood test could see personalised prostate cancer treatment

www.theguardian.com

Revolutionary three-in-one blood test could change treatment for advanced stages of disease, say scientists.

Blood test may show if prostate cancer treatment is working

www.nhs.uk

A study found a blood test could detect which men with advanced prostate cancer would benefit from new drug treatment. Researchers analysed blood samples from nearly 50 men taking part in a trial of a new drug (olaparib) for prostate…

New test may turn AZ's Lynparza into precision drug for prostate cancer

www.reuters.com

LONDON, June 19 (Reuters) - Scientists have developed a new

Lynparza might become standard weapon for advanced prostate cancer

Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca’s drug Lynparza into a precision medicine for prostate cancer. Lynparza, which is already approved for ovarian and recently produced good…

New test may turn AZ's Lynparza into precision drug for prostate cancer

Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca's drug Lynparza into a precision medicine for prostate cancer.

Medical News Today: Prostate cancer: Three-in-one blood test could fuel personalized treatment

A single blood test could identify how prostate cancer patients will respond to PARP inhibitors in as little as 4 to 8 weeks, say researchers.

Prostate Cancer Drug: 3-in-1 Test Could Turn Astrazeneca's Lynparza Into a Precision Treatment

europe.newsweek.com

The test can also quickly detect if prostate cancer is evolving genetically and might be becoming drug-resistant.